We have detected that you are using an Ad Blocker. PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
No comments yet, be the first to start the discussion!
According to ASCO Guidelines there is no a clear role for a systemic therapy in case systemic disease is not progressive at the time of brain metastasis diagnosis. However the quality of evidence is low and, sincerely, I would not feel so confident to leave such a young and high risk patient without a systemic treatment at all. Probably I would consider TDM-1, but the other problem would be....how long?
Pending Moderator approval.
Are you sure you want to delete this comment? This can't be undone.